Whalegun
Home

Neurocrine Biosciences NBIX paid Ricchetti $50K for lobbying in Q4 2022 · Medicare, Pharmacy and 1 more issue

Trade details

Type
Lobbying report
Amount
$50,000
Quarter
Q4 2022
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
23/01/18

$940K on lobbying in 2022

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Neurocrine Biosciences's other lobbying reports